Call Now Open

2025 Oxford-Harrington Rare Disease Scholar Award

You've just added:

Home / News

News + Media

February 05, 2025

Synergy for Change Award to Morgan Stanley GIFT and Harrington Discovery Institute

Award highlights collaboration between for profit and non-profit achieving great impact Continue Reading

January 13, 2025

2023-2024 Harrington Annual Publication

Next Generation Medicines Continue Reading

December 03, 2024

AlveoGene’s Novel, Inhaled Gene Therapy AVG-002 Receives Orphan Drug Designation from FDA for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency

Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infants with few, if any, options for long-term survival Continue Reading

November 15, 2024

AlveoGene Receives Rare Pediatric Disease Designation (RPDD) from FDA for AVG-002, its Novel, Inhaled Gene Therapy for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency

Oxford, UK – 15th November 2024 – (or ‘the Company’, www.alveogene.com), a company focused on transforming rare respiratory disease outcomes using inhaled gene therapy, announces that it has been granted a Rare Pediatric Disease Designation (RPDD) by the US Food & Drug Administration (FDA) for AVG-002, its novel... Continue Reading

October 24, 2024

The Oxford-Harrington Rare Disease Centre (OHC) Announces Inaugural 2024 Rare Disease Scholar Award Recipients

10 scientists have been selected for OHC’s first annual award to advance academic discoveries into clinical practice for rare diseases Continue Reading

October 15, 2024

Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council

Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years Continue Reading

September 26, 2024

Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2025 Harrington-MSTP Scholar Award

Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines Continue Reading

September 24, 2024

Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments

The Symposium explores how cutting-edge research, innovative treatment strategies, and collaboration is driving the development of effective therapies for rare diseases. Continue Reading

September 17, 2024

Acutely blocking excessive mitochondrial fission prevents chronic neurodegeneration after traumatic brain injury

Progression of acute TBI to chronic neurodegeneration is a major health problem with no protective treatments. Time sensitive inhibition of acutely elevated mitochondrial fission may present a way to protect patients from chronic neurodegeneration. Continue Reading

September 11, 2024

Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council

In her position on OHC’s Advisory Council, Baroness Blackwood will contribute to advancing OHC’s mission to drive life-changing discoveries in rare disease, with a particular focus on addressing critical unmet needs in the UK. Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.